2m 2m 2m 2m 2m 2m 2m
CareDx (CDNA)
NASDAQ
$25.35+$0.30 (+1.20%)
Price as of Jun 23, 2026 7:58 PM EDT- $1.3BMarket Cap
- 32.19%1-Year Change
- Diagnostics & ResearchIndustry
CareDx (CDNA)
$25.35+$0.30 (+1.20%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 274.5M -17.76% | 333.8M +19.07% | 280.3M -12.91% | 321.9M +8.57% | |
Cost of Revenue | 62.0M -70.70% | 211.8M +107.62% | 102.0M -9.10% | 112.2M +15.22% | |
Gross Profit | 212.4M +74.12% | 122.0M -31.58% | 178.3M -14.95% | 209.7M +5.31% | |
Sales and Marketing Expense | 102.6M +25.61% | 81.7M -1.94% | 83.3M -13.22% | 96.0M +24.31% | |
Research and Development Expense | -71.4M -1.35% | -72.4M -11.56% | -81.9M -9.43% | -90.4M +18.12% | |
Depreciation and Amortization Expense | 15.0M +5.81% | 14.2M -1.33% | 14.4M +24.07% | 11.6M +31.81% | |
Total Operating Expenses | 410.6M +40.12% | 293.0M -39.42% | 483.7M +21.22% | 399.0M +22.35% | |
Operating Profit | -30.8M -175.51% | 40.8M +120.05% | -203.4M +163.32% | -77.2M +159.81% | |
Interest Income | 0 N/A | 0 -100.00% | 2.1M N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 -100.00% | 2.1M N/A | 0 N/A | |
Total Nonoperating Income and Expense | 9.7M -19.81% | 12.1M -8.52% | 13.2M +1,225.98% | 997,000 +142.21% | |
Income before Taxes | -21.1M -139.89% | 52.9M +127.80% | -190.1M +149.42% | -76.2M +137.58% | |
Income Taxes | 271,000 -12.58% | 310,000 +119.86% | 141,000 -62.80% | 379,000 +126.58% | |
Extraordinary Items | 2.3M N/A | 0 -100.00% | 1.0M +19.05% | 840,000 -65.53% | |
Net Income | -21.4M -140.64% | 52.5M +127.62% | -190.3M +148.37% | -76.6M +149.86% | |
Net Income from Continuing Operations Applicable to Common | -21.1M -139.89% | 52.9M +127.80% | -190.1M +149.42% | -76.2M +137.58% | |
Basic EPS and Net Income | -0.40 -140.00% | 1.00 +128.25% | -3.54 +145.83% | -1.44 +144.07% | |
Diluted EPS and Net Income | -0.40 -143.01% | 0.93 +126.27% | -3.54 +145.83% | -1.44 +144.07% | |
Basic Weighted Average Shares | 53.3M +0.97% | 52.8M -1.84% | 53.8M +0.83% | 53.3M +2.07% | |
Diluted Weighted Average Shares | 53.3M -5.89% | 56.6M +5.31% | 53.8M +0.83% | 53.3M +2.07% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 65.4M -42.95% | 114.7M +39.53% | 82.2M -8.59% | 89.9M -74.20% | |
Short-Term Investments | 111.8M -23.42% | 146.0M -4.74% | 153.2M -24.58% | 203.2M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 177.2M -32.01% | 260.7M +10.72% | 235.4M -19.68% | 293.1M -15.90% | |
Total Current Assets | 257.1M -26.92% | 351.8M +12.15% | 313.7M -19.11% | 387.8M -10.50% | |
Accumulated Depreciation | 38.9M +5.17% | 36.9M +14.50% | 32.3M +32.10% | 24.4M +24.73% | |
Property and Plant and Equipment and Net | 33.0M -1.73% | 33.6M -4.81% | 35.2M -0.80% | 35.5M +61.17% | |
Total Long-Term Assets | 3.4M +50.97% | 2.2M +64.15% | 1.4M -64.66% | 3.8M -34.40% | |
Total Assets | 413.2M -15.85% | 491.1M +5.19% | 466.8M -14.03% | 543.0M -4.17% | |
Income Taxes Payable | 181,000 +10.37% | 164,000 +20.59% | 136,000 N/A | 0 -100.00% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 89.8M +0.53% | 89.4M +14.47% | 78.1M +2.76% | 76.0M -1.72% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 257,000 -60.16% | 645,000 -99.33% | 96.6M +38,675.50% | 249,000 -45.27% | |
Total Liabilities | 110.1M -2.21% | 112.6M -45.20% | 205.5M +83.35% | 112.1M +11.25% | |
Retained Earnings | -735.4M +17.42% | -626.2M -7.67% | -678.3M +47.31% | -460.4M +20.16% | |
Total Stockholders Equity | 303.1M -19.91% | 378.4M +44.81% | 261.3M -39.35% | 430.9M -7.51% | |
Total Shares Outstanding | 50.9M -7.04% | 54.8M +6.34% | 51.5M -3.79% | 53.5M +1.15% | |
Cash Flow | |||||
Cash from Operating Activities | 42.0M +10.47% | 38.0M +306.92% | -18.4M -27.14% | -25.2M +30.81% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 2.2M +546.79% | -483,000 -101.19% | 40.4M +117.70% | -228.5M -578.92% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -93.4M +1,565.97% | -5.6M -81.06% | -29.6M +552.83% | -4.5M -102.44% | |
Financials Ratio | |||||
Gross Margin | 77.40% +111.73% | 36.56% -42.54% | 63.62% -2.34% | 65.14% -3.00% | |
Operating Margin | -11.21% -191.82% | 12.21% +116.84% | -72.54% +202.36% | -23.99% +139.31% | |
Return on Assets | -4.72% -143.05% | 10.97% +129.11% | -37.69% +172.91% | -13.81% +110.57% | |
Return on Equity | -6.27% -138.15% | 16.43% +129.88% | -54.98% +221.76% | -17.09% +107.17% | |
Revenue Growth | -17.76% -193.16% | 19.07% +247.66% | -12.91% -250.75% | 8.57% -84.56% | |
Current Ratio | 2.86 -27.31% | 3.94 -2.03% | 4.02 -21.29% | 5.11 -8.94% | |
Cash Ratio | 0.73 -43.26% | 1.28 +21.89% | 1.05 -11.05% | 1.18 -73.75% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow